Sarcoma: open trials in Denmark

20 open trials have a site in Denmark. Registry data; only the trial team decides who can take part.

NCT06395103
Substudy 01A: Zilovertamab Vedotin in Pediatric and Young Adult Participants With Hematologic Malignancies or Solid Tumors (MK-9999-01A/LIGHTBEAM-U01)
Trial Treatment · Phase 1/2 · Merck Sharp & Dohme LLC
Rigshospitalet, Copenhagen Oe
Registry updated 2026-10-30
NCT07871864
Fight Osteosarcoma Through European Research Evolving Study Platform From Diagnosis to Relapse
Trial Treatment · Phase 3 · Gustave Roussy, Cancer Campus, Grand Paris
Aarhus University Hospital, Department of Paediatric and Adolescent Medicine, Aarhus · Aarhus University Hospital, Department of Oncology, Aarhus · Rigshospitalet, Copenhagen University Hospital, Department of Paediatric and Adolescent Medicine, Copenhagen · Herlev Hospital, Department of Oncology, Herlev
Registry updated 2026-10-26
NCT07261631
Phase I Study of [177Lu]Lu-DFC413 in Patients With Solid Tumors
Trial Treatment · Phase 1 · Novartis Pharmaceuticals
Novartis Investigative Site, Odense C
Registry updated 2026-10-09
NCT04031677
Surgery With or Without Neoadjuvant Chemotherapy in High Risk RetroPeritoneal Sarcoma
Trial Treatment · Phase 3 · European Organisation for Research and Treatment of Cancer - EORTC
Aarhus University Hospitals - Aarhus University Hospital-Skejby, Aarhus · Herlev Hospital - University Copenhagen, Herlev
Registry updated 2026-10-07
NCT07861217
Paediatric Sarcoma, Hybrid Imaging & FAPI - Raising the Diagnostic Standard for Paediatric Sarcoma Patients, Combining Novel Radiotracer FAPI and Whole-body PET/MRI
Trial Treatment · Phase 2 · Copenhagen University Hospital, Rigshospitalet
Rigshospitalet, Copenhagen Oe
Registry updated 2026-10-06
NCT06760819
A Study to Learn More About How Well Treatment With Sevabertinib (BAY 2927088) Tablets Works and How Safe it is in Participants Who Have a Solid Tumor With Mutations of the Human Epidermal Growth Factor Receptor 2 (HER2)
Trial Treatment · Phase 2 · Bayer
Aarhus University Hospital | Oncology Department - Clinical Research Unit, Aarhus N · Rigshospitalet Copenhagen University Hospital | Oncology Department, Copenhagen · Odense University Hospital | Svendborg Sygehus - Oncology Department, Odense
Registry updated 2026-10-02
NCT06884618
A Study to Evaluate the Safety, Tolerability, Pharmacokinetics (PK) and Preliminary Clinical Activity of RO7673396 in Participants With Advanced Solid Tumors Harboring Rat Sarcoma Viral Oncogene Homolog (RAS) Mutation(s)
Trial Treatment · Phase 1 · Hoffmann-La Roche
Rigshospitalet, København Ø
Registry updated 2026-09-28
NCT04094610
A Study of Repotrectinib in Pediatric and Young Adult Subjects Harboring ALK, ROS1, OR NTRK1-3 Alterations
Trial Treatment · Phase 1/2 · Turning Point Therapeutics, Inc.
Rigshospitalet, Copenhagen Oe
Registry updated 2026-09-25
2025-521702-18-00
A phase I open-label, multi-center study to evaluate the safety, tolerability, dosimetry, and preliminary activity of [177Lu]Lu-DFC413 and safety and imaging properties of [68Ga]Ga-NNS309 in patients with solid tumors
Trial Treatment · Phase 1 · Novartis Pharma AG
Rigshospitalet, Copenhagen Oe · Odense University Hospital, Odense C
Registry updated 2026-09-15
NCT07630961
Phase I Study of JFI447 [68Ga]Ga-DFC413 and Comparison to FFG233 [68Ga]Ga-NNS309 in Patients With Solid Tumors
Trial Treatment · Phase 1 · Novartis Pharmaceuticals
Novartis Investigative Site, Odense C
Registry updated 2026-08-27
NCT07785882
Sarcoma and Intra-infusion Exercise for Better Outcomes
Trial Treatment · Kira Bloomquist
Department of Oncology, Herlev Hospital, Herlev
Registry updated 2026-08-25
NCT07134192
Fluorescence-Guided Optimization of Sarcoma Margins
Trial Treatment · University of Aarhus
Aarhus University Hospital, Aarhus N · Rigshospitalet, Copenhagen
Registry updated 2026-07-01
NCT07145450
Master Protocol of TCR-modified T Cell Therapy Targeting HLA-restricted KRAS Antigen Administered in Adult Patients With Metastatic or Locally Advanced PDAC
Trial Treatment · Phase 1/2 · Anocca AB
Herlev and Gentofte University Hospital, Copenhagen
Registry updated 2026-06-08
NCT03093116
A Study of Repotrectinib (TPX-0005) in Patients With Advanced Solid Tumors Harboring ALK, ROS1, or NTRK1-3 Rearrangements
Trial Treatment · Phase 1/2 · Turning Point Therapeutics, Inc.
Copenhagen University Hospital, Copenhagen Oe
Registry updated 2026-05-27
NCT06408441
The Epithelioid Hemangioendothelioma Registry of the European Reference Network on Rare Adult Solid Cancers (EURACAN)
Research · Fondazione IRCCS Istituto Nazionale dei Tumori, Milano
Aarhus University Hospital, Aarhus
Registry updated 2026-04-03
NCT07450950
Evaluating Health Literacy, Expectations and Regrets in Patients Undergoing Major Abdominal Surgery for Malignant Disease
Research · Copenhagen University Hospital, Rigshospitalet
Rigshospitalet, Copenhagen
Registry updated 2026-03-05
2024-516078-31-00
rEECur: International Randomised Controlled Trial of Chemotherapy for the Treatment of Recurrent and Primary Refractory Ewing Sarcoma
Trial Treatment · Phase 2/3 · The University Of Birmingham
Region Midtjylland, Aarhus N · Rigshospitalet, Copenhagen Oe · Region Hovedstaden, Herlev
Registry updated 2024-12-04
NCT04625907
FaR-RMS: An Overarching Study for Children and Adults With Frontline and Relapsed RhabdoMyoSarcoma
Trial Treatment · Phase 1/2 · University of Birmingham
Region Midtjylland, Aarhus N · Rigshospitalet, Copenhagen Oe · Region Hovedstadens Apotek Herlev Hospital, Herlev
Registry updated 2024-05-23
NCT05961761
Propranolol and Pembrolizumab in Advanced Soft Tissue Sarcoma Patients
Trial Treatment · Phase 2 · Niels Junker
Aarhus Universitetshospital, Aarhus N · Region Hovedstaden, Herlev
Registry updated 2023-07-27
NCT05840575
Investigating Cognitive Impairment in Young Patients With Cancer Prospectively
Research · Copenhagen University Hospital, Rigshospitalet
Rigshospitalet, Copenhagen
Registry updated 2023-05-03

All Sarcoma trials and the map

This page is not medical advice. Talk to your doctor before contacting a trial.

Report an error